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Between 1984 and 1993 we performed 2105 laser treatments in 1210 patients: 52% of treatments
were done for malignant pathology, 45% for benign tracheal stenoses and 3% were in a miscella-
neous group. The procedure was carded out with a rigid bronchoscope under general anaesthesia. In
patients with malignant tumors, it is a good palliative treatmentmsafe, well tolerated and with im-
mediate results; it can be repeated as many times as needed with and is well accepted by the patient.
In patients without tumors, this method avoids emergency tracheotomies. The long term results are
now under evaluation.
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INTRODUCTION
Since the 1930’s, there has been a clear desire to elimi-
nate, through endoscopic methods, large tumoral or ia-
trogenic obstructions of the airways. In 1935, Kramer and
Som (1) published the first results of endoscopic resec-
tion in 20 patients with bronchial adenoma, observing
years later that of the 14 patients that they had considered
adequately treated, 50% were cured or free of symptoms
(2). Further attempts to endoscopically resect malignant
lesions were soon abandoned because postulated im-
provements in ventilation were offset by the significant
risk of hemorrhagic complications (3). More recently,
transbronchoscopic cryosurgery (4) and intraluminal ra-
diotherapy (5) have been tried with limited benefits in the
removal of the bronchial obstruction.
Endobronchial laser treatmenthas shown promise since
the first report ofStrong and colleagues in 1974 (6). Since
then the use of lasers in the tracheobronchial tree has con-
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tinued to advance. Since the 1980’s, laser bronchoscopy
has reached its apogee, as demonstrated in the extensive
published series (7-10). This report presents some con-
siderations after 9 years experience with 2015 procedures.
MATERIALS AND METHODS
Between 1984 and 1993 we performed a total of 2105
treatments in 1210 patients (Fig. 1). These consisted of
1094 (52%) treatments for tumors, 947 (45%) for tracheal
stenosis and64 (3%) treatments for a miscellaneous group
that included granulomas, small recurrences of bronchial
carcinoma on suture scars, management of local bleeding
and dislodgement ofimpacted foreign bodies. Most of the
procedures were carried out with a rigid bronchoscope and
under general anesthesia.
Instruments
Transmission Apparatus ofthe Laser
The Nd-YAG laser is well suited to the treatment of tra-
cheobronchial pathology because of its tissue penetration
and its great capacity for coagulation. Its energy source80 J.P. DIAZ-JIMENEZ et al.
LASER PHOTORESECTION
TUMORS 52%
MISCELLANEOUS 3
TRACHEAL STENOSIS 45%
TOTAL PROCEDURES 2105.TOTAL PTS 1210
Figure 1 Total Experience.
can emit energy in the range of 0 to 100 watts. Emission
of the laser beam is controlled by a foot pedal operated by
the bronchoscopist.
In our system, the laser is transmitted from the genera-
tor to the tissues through a fiber 0.6 mm in diameter, sur-
rounded by a Teflon sleeve through which gas (nitrogen)
is passed to obtain cooling and to prevent combustion.
Since the light of the Nd-YAG laser is invisible to the
human eye, a coaxial red helium-neon laser is used for tar-
geting. The distal end is protected by a metallic tube of
stainless steel to avoid ignition by overheating during
treatment. Recently, disposable fibers have been devel-
oped which allow either contact or non-contact applica-
tions. These fibers are able to cut (approximating the CO2
effect in the tissue) and to coagulate.
Endoscopes
The rigid bronchoscope (Fig. 2) we employ for photore-
section has a principal tube of 14 mm in diameter.
Through this tube the following can be introduced: laser
transmission fiber, forceps and narrower diameter
bronchial tubes. This gives the bronchoscopist access to
4 to 10 mm diameter airways. At the main opening, a
swiveling head is connected with a lateral port for venti-
lation. Two other lateral apertures allow the introduction
of semirigid aspiration catheters and the laser fiber. An
optional guide to fix the laser fiber can be used to improve
the precision ofthe beam. A fiberoptic bronchoscope with
an aspiration channel greater than 2.1 mm in diameter can
be used in small resections, but is more commonly intro-
duced through the rigid bronchoscope to clear the
bronchial tree of blood, secretions or detritus at the end
of the intervention.
Method
The majority of the treatments are done with a rigid bron-
choscope and under general anesthesia. Adequate anes-
thesia is fundamental for the success of these treatments.
Since we ventilate the patient through the rigid broncho-
scope with an open circuit, the patient is ideally asleep,
breathing spontaneously, with the cough reflex abolished.
It is extremely important to avoid oxygen concentrations
over 50% because of the danger of explosion or ignition
during the bursts of laser emissions.
Once the patient is anesthetized and appropriate mon-
itoring is established, we proceed to intubation and ven-
tilation through the rigid bronchoscope. We then inspect
the airway. Care is taken to avoid contact with the lesion
at this point so we can best define the limits of the lesion
and avoid hemorrhage, which would obscure the field. A
thorough understanding of thoracic anatomy is necessary
to prevent iatrogenic damage to important surrounding
structures. The limits of the lesion are defined by imag-
ing studies (i.e., X-rays, tomograms, computed tomogra-LASER PHOTORESECTION IN TRACHEOBRONCHIAL PATHOLOGY 81
Figure 2 Rigid bronchoscope for laser treatments.
phy scans, esophograms, etc.) performed in addition to
routine preoperative studies.
The first few bursts of laser photoradiation are used to
estimate the tissue energy absorption characteristics and
the depth of the laser penetration. We vary the power and
the duration of the laser shots as the treatment progresses.
We use short bursts at high energy to resect tumor and
longer bursts at low energy to coagulate. We never use a
continuous pattern of firing as we consider this to be un-
safe. The beam of the Nd-YAG laser, which is always
coaxial with the fiber could damage surrounding struc-
tures. The tip of the bronchoscope can be used as an ad-
ditional aid to ablate and remove tissue incised by the
laser beam.
RESULTS
Our total experience include 2105 resections in 1210 pa-
tients. As laser photoresection is almost always a pallia-
tive rather than a curative procedure, immediate results
were classified as excellent, good or poor according to ini-
tial improvement of symptoms and airway diameter.
Excellent results were achieved in 71.6% of tracheal tu-
mors. Of the patients with tracheal stenosis, 35% had re-
currences and underwent a repeat laser photoresection,
surgery orprosthesis placement (Fig. 3). In the past 2 years,
we placed a total of 125 stents for both malignant tumors
(84/68%) and benign tracheal stenosis (41/32%) (Fig. 4).
The most significant complication of stenting was migra-
tion which was greater with underlying benign pathology
than with underlying malignant pathology.
DISCUSSION
Malignant Tumor Pathology
Laser photoresection of tumors is limited to inoperable
cases. These include cases of tumor that has gone beyond
the limits of resection or in which the condition of the pa-
tient precludes surgery. The objective always has to be re-
lief of obstruction (Fig. 5), regardless of the histological
type of tumor. The reestablishment of the airways by pho-
toresection represents the most important palliative treat-
ment because it can immediately correct ventilatory
compromise. It also facilitates drainage of the secretions
that can cause infection, and it can control hemoptysis
(11-14). The therapy helps retard the endobronchial pro-
gression ofthe neoplasia within the airways and especially
towards the trachea or contralateral side. In patients with
malignant tumors with peripheral obstruction and conse-
quent pneumonitis or abscess, the widening of the82 J.P. DIAZoJIMENEZ et al.
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Figure 4 Immediate results for tracheal stenosis.
bronchus with laser therapy with resulting improved
drainage can relieve infection and is beneficial even
though we know there is no improvement in the ventila-
tion/perfusion index (15). In cases of large central tumors
that invade the pulmonary artery, the improvement ofven-
tilation without perfusion results in a poor functional re-
sult. Nevertheless, the treatment is indicated to retard the
growth of the tumor toward the trachea or toward the con-
tralateral side in order to avoid death by asphyxia.
Low Grade Malignant Tumors
In cases of carcinoid tumors and tumors deriving from
bronchial glands (i.e. adenoid cystic carcinoma and mu-
coepidermoid tumor), laserphoteresection is reserved for
inoperable tumors. The most serious risk in the endo-
bronchial resection of carcinoid tumor is hemorrhage.
This can be reduced by using the laser for coagulation
and other local approaches, such as compression with the
rigid bronchoscope. With cylindroma, laser resection
may be the only means ofreliefofobstruction since these
tumors are found with greater frequency in the trachea,
and at times may even extensively involve both main
bronchi. Their tendency to be locally invasive is related
to frequent recurrence. A mucoepidermoid tumor, be-
cause of its polypoid form, can be confused macroscop-
ically with a benign tumor. Its resection is not associated
with many complications (16).
Benign Tumors
Benign tumors constitute the best indication for photore-
section. Unfortunately, the frequency of benign tumors is
less than malignant tumors. They include hamartomas,
lipomas, chondromas, leiomyomas, etc., and represent a
rare group in terms of endobronchial pathology. Their ex-
ternal appearance is similar: pale, small, round, poorly vas-
cularized and, in general, pedunculated. Resection is
simple and almost always definitive. The recurrence rate
is low (8,9).
Diffuse tracheobronchial amyloidosis is a unique con-
dition. Photoresection is difficult because of the diffuse
extension and the tendency for bleeding. Repeat proce-
dures are often needed. Diffuse tracheal papillomatosis is
more problematic in children in whom it is frequently as-
sociated with laryngeal papillomatosis (18-20).
Tracheal Stenosis
Tracheal stenosis is a dynamic pathological entity of the
trachea, with tissue growing within the lumen and frequent
involvements ofthe supporting structures. Formany years
prolonged intubation for mechanical ventilation and life
support has been used. The widespread use of endotra-
cheal tubes with low pressure and high volume balloons
and tracheostomies in patients who need prolonged as-
sisted ventilation has diminished, but not eliminated, the
complications ofrespiratory support. Today, endotracheal
intubation is the most frequent cause of tracheal stenosis.
Tracheal stenosis can be at one or at various levels. The
same endotracheal tube used to treat tracheal stenosis can
be the cause of laryngeal obstruction as a consequence of
edema, granulomas or erosions (21,22). The balloon can
cause ischemia and necrosis of the mucosa and cartilage.
This can lead to the formation of granulation tissue and
scarfing that cause circumferential stenosis. This type of
lesion is usually located between the fourth and seventh
tracheal rings. Less frequently, an endotracheal tube that
is not well centered and consequently repeatedly irritates84 J.P. DIAZ-JIMENEZ et al.
Figure 5a Endobronchial tumor before treatment.
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and erodes the mucosa can lead to the formation of gran-
ulomas at the edge of a tracheotomy, at the bend of the
cannula, or at the distal tip ofthe tube and this can progress
to stenosis. Infection, loss ofcartilaginous support and tra-
cheomalacia exacerbate these processes.
Treatment aims to reestablish the airway by endoscopic
procedures or by an external surgical approach. Surgical
procedures such as resection ofthe affected rings and end-
to-end anastomosis, tracheoplasty, etc., carry certain po-
tential risks not usually associated with endoscopic
resection. These include an increased anesthesiatime, pro-
longed hospitalization, loss ofblood and problems related
to the transfusion, and postoperative discomfort of the pa-
tient. Repeated procedures, if needed, are difficult.
Endoscopic methods include traditional dilatation,
which in itself is not free of risk, prolonged placement of
a fixed dilating prothesis, the use of lasers, or combined
laser and stenting (Fig. 6) The treatment oftracheal steno-
sis with a laser treatment is simple and results can be spec-
tacular. The airway is reestablished in a few minutes,
independent of the grade of obstruction or of location.
This makes laser treatment the fastest and safest method
for tracheal stenosis. Unfortunatelly, many of these re-
opened stenoses will not remain open for more than 2
months because the mechanism for formation of tracheal
stenosis involves not only the growth of granulation or fi-
brotic tissue into the tracheal lumen, but also a failure of
the supporting structures. The conclusion ofmany authors
(7-9,23-25) is that the best results are obtained in patients
with diaphragmatic stenosis extending less than 1 cm along
the longitudinal axis of the trachea and with no destruction
of the wall structures. In these patients, the effects of treat-
mentofthe stenosis are usually permanent. In patients with
more complex stenosis, the recurrence rate varies between
50 and75% (23-26). The recommendation is to always try
laser treatment first and, if there is recurrence, proceed to
surgical correction or stent placement (27-32).
Complications, Accidents and Their Prevention
Massive hemorrhage with resulting hypoxemia and per-
foration of surrounding structures are the most serious
complications that can be encountered during laser pho-
toresection. These can be avoided in the majority of cases
with good patient selection and technique. The most seri-
ous risk derives from poor ventilation. In essence, many
of these patients have serious ventilatory insufficiency or
failure consequent to the obstruction that has motivated
the treatment. Therefore, the principal objective is a rapid
tracheal or bronchial reopenning that is enough to resolve
the functional respiratory problem. A timid or insufficient
attempt at reopening can accentuate the obstruction (8).
When significant hemorrhage is produced during
treatment, steps are taken to contain the hemorrhage and
to keep the airways well ventilated. If bleeding is pro-
duced by a lesion situated in the trachea, we pass the le-
sion with the rigid bronchoscope. Our goal is to initially
compress the point of hemorrhage and ventilate the
bronchial tree. We later coagulate with the laser. With
bronchial lesions, we withdraw the bronchoscope to the
trachea to ventilate the contralateral side while we aspi-
rate the blood out to the airway and try to stop the hem-
orrhage with local intervention such as using the laser
for coagulation.
Perforation of surrounding structures is very rare, but
when it does occur, it is usually catastrophic. It is best to
avoid this by using good technique, avoiding direct laser
shots to the tracheal or bronchial walls and not stubbornly
continuing the resection when the involved tissue does not
absorb the laser beam well since this can be deeply dam-
aging the surrounding structures (7,33,34).
The mortality rate during treatment varies according to
the reported series. It is lower among those using a rigid
bronchoscope (7-9) than in those using a fiberoptic bron-
choscope (35,36). Despite the fact that some authors
(15,37-39) findno difference in the results withboth meth-
ods, we believe the margin of safety with the rigid bron-
choscope is superior to the flexible bronchoscope. This is
because of better visibility and the ability to introduce as-
piration tubes and forceps, effect compression, and incise
tissues with the laser. Also, the time needed for the inter-
vention is less. The flexible bronchoscope can be intro-
duced through the rigid bronchoscope to treat more distal
areas. All these make treatment with a rigid bronchoscope
superior to using a flexible bronchoscope alone. Risks are
further minimized using laser energies of no greater than
45 watts and by maintaining oxygen levels of less than
50% during laser emission. There are several reports like
that of Casey and colleagues (41), of an endotracheal ig-
nition of the fiberbronchoscope when using high energy
laser bursts in the presence of high concentrations of
oxygen. Finally, other infrequent complications have been
reported. These include pneumothorax or pneumomedi-
astinumwhich usually occur in relation to mechanical ven-
tilation during anesthesia, especially when jet ventilation
is used (42,43). There has even been a case reported of the
loss of the metallic protector of the distal end of the laser
fiber because of excessive heating (44).
CONCLUSION
Overall, laser bronchoscopy has made a significant con-
tribution to the treatment of intraluminal airway disease.
It can be used in conjunction with other forms of therapy.86 J.P. DIAZ-JIMENEZ et al.
Figure 6a Bronchial stenosis before treatment.
Figure 61 Same stenosis after photoresection and stent placement.LASER PHOTORESECTION IN TRACHEOBRONCHIAL PATHOLOGY 87
It can provide significant palliation in patients with ma-
lignant or benign airway tumors who are not candidates
for surgery. It also may spare some patients with tracheal
stenosis the need for more invasive surgery. With care
taken for good patient selection and technique, laser pho-
toresection represents a low risk option to achieve signif-
icant palliation in patients with benign and malignant
conditions compromising the airway.
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